Basiliximab January 19, 2018 Basiliximab Trade Name Simulect Orphan Indication Prophylaxis of solid organ rejection USA Market Approval USA USA Designation Date 1997-12-12 00:00:00 Sponsor Novartis Pharmaceuticals Corporation;59 Route 10;East Hanover, New Jersey, 07936
